Ortec launches OrCel through PDI:
This article was originally published in Clinica
Executive Summary
Ortec International is to launch OrCel, a biologically active wound agent, from this quarter, with a dedicated sales force from sales and marketing company PDI. The two companies will target the $100 million donor site burn market. New York-based Ortec says its product is the only one containing living human cells that is FDA-approved for healing donor site wounds in burn patients. At a later stage, Ortec plans "a collaboration with or acquisition by a large, woundcare focused marketing and distribution company" for the venous and diabetic ulcer markets.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.